Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)

NCT ID: NCT05700994

Last Updated: 2026-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

1283 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-13

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of methamphetamine (MA) harm reduction services.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using a hybrid type 1 effectiveness-implementation framework and stepped-wedge design, this study will randomize eighteen community-based peer harm reduction sites to provide contingency management incentives for achieving self-identified harm reduction goals set with peer specialists using a participant-driven harm reduction goal-setting process (e.g. completing overdose prevention and supply training, daily life goals, treatment and care goals, relationship and social support goals) versus standard of care contingency management (i.e. incentives for peer encounter attendance).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Methamphetamine Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

This is a cluster-randomized pragmatic trial using a hybrid type 1 effectiveness-implementation framework and stepped-wedge design.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEER-CM

Peer-facilitated contingency management (PEER-CM).

Group Type EXPERIMENTAL

Peer Contingency Management

Intervention Type BEHAVIORAL

Participants allocated to peer-facilitated contingency management will receive incentives for achieving self-identified harm reduction goals set with peer specialists using a participant-driven harm reduction goal-setting process (e.g. completing overdose prevention and supply training, daily life goals, treatment and care goals, relationship and social support goals)

Standard of Care

Standard of care contingency management.

Group Type ACTIVE_COMPARATOR

Standard of Care Contingency Management

Intervention Type BEHAVIORAL

Participants allocated to standard of care contingency management will receive incentives for peer encounters.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Peer Contingency Management

Participants allocated to peer-facilitated contingency management will receive incentives for achieving self-identified harm reduction goals set with peer specialists using a participant-driven harm reduction goal-setting process (e.g. completing overdose prevention and supply training, daily life goals, treatment and care goals, relationship and social support goals)

Intervention Type BEHAVIORAL

Standard of Care Contingency Management

Participants allocated to standard of care contingency management will receive incentives for peer encounters.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PEER-CM Standard of Care

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

This intervention is at the site level. Community-based organization sites are eligible if they:

* Use peer support specialists to provide direct outreach and harm reduction services to people who use drugs
* Are willing to be trained in the two strategies for peer-facilitated contingency management

Clients who:

* Age 18 and older
* Any stimulant (methamphetamine, cocaine) use in the past 30 days
* Willing to accept peer services
* Willing to complete initial and follow-up assessments with peer
* Able to communicate in English or Spanish

Exclusion Criteria

Community-based organization sites who:

* Do not use peer support specialists to provide direct outreach and harm reduction services to people who use drugs
* Are not willing to be trained in the two strategies for peer-facilitated contingency management

Clients who:

• Present any danger or threat of violence to peers
Minimum Eligible Age

18 Years

Maximum Eligible Age

105 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Comagine Health

OTHER

Sponsor Role collaborator

Oregon Health Authority

OTHER

Sponsor Role collaborator

Oregon Health and Science University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

P. Todd Korthuis, MD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Comagine Health

Portland, Oregon, United States

Site Status

Oregon Health & Science University

Portland, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Cooke A, Stack E, Peng L, Cook R, Hartzler B, Leichtling G, Hildebran C, Leahy JM, Payne KS, Kunkel LE, Hoffman K, Korthuis PT. The peers expanding engagement in stimulant harm reduction with contingency management study: a protocol paper. Addict Sci Clin Pract. 2025 Jun 10;20(1):48. doi: 10.1186/s13722-025-00577-8.

Reference Type DERIVED
PMID: 40495203 (View on PubMed)

Peng L, Stack E, Cooke A, Hartzler B, Cook R, Leichtling G, Hildebran C, Leahy J, Payne KS, Kunkel L, Hoffman K, Korthuis PT. Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals. Harm Reduct J. 2025 May 6;22(Suppl 1):72. doi: 10.1186/s12954-025-01213-z.

Reference Type DERIVED
PMID: 40329274 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEER-CM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Monitoring and Feedback in Substance Abuse Treatment
NCT01465490 COMPLETED PHASE1/PHASE2
Voucher-Based Incentives in a Prevention Setting
NCT00607269 COMPLETED PHASE2/PHASE3